WO2023010925A1 - 一种近红外二区荧光小分子的制备方法 - Google Patents
一种近红外二区荧光小分子的制备方法 Download PDFInfo
- Publication number
- WO2023010925A1 WO2023010925A1 PCT/CN2022/091633 CN2022091633W WO2023010925A1 WO 2023010925 A1 WO2023010925 A1 WO 2023010925A1 CN 2022091633 W CN2022091633 W CN 2022091633W WO 2023010925 A1 WO2023010925 A1 WO 2023010925A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- add
- infrared
- small molecule
- fluorescent
- fluorescent small
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 64
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 48
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 42
- 150000003384 small molecules Chemical class 0.000 claims description 41
- 230000015572 biosynthetic process Effects 0.000 claims description 35
- 238000003786 synthesis reaction Methods 0.000 claims description 34
- 238000006243 chemical reaction Methods 0.000 claims description 33
- 229910052757 nitrogen Inorganic materials 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 238000003756 stirring Methods 0.000 claims description 26
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 24
- 239000003054 catalyst Substances 0.000 claims description 24
- 239000000047 product Substances 0.000 claims description 21
- 239000002904 solvent Substances 0.000 claims description 19
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 18
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical group C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 17
- XJHABGPPCLHLLV-UHFFFAOYSA-N benzo[de]isoquinoline-1,3-dione Chemical class C1=CC(C(=O)NC2=O)=C3C2=CC=CC3=C1 XJHABGPPCLHLLV-UHFFFAOYSA-N 0.000 claims description 16
- 239000003381 stabilizer Substances 0.000 claims description 14
- 238000004440 column chromatography Methods 0.000 claims description 13
- 239000011259 mixed solution Substances 0.000 claims description 12
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 11
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- ULTHEAFYOOPTTB-UHFFFAOYSA-N 1,4-dibromobutane Chemical compound BrCCCCBr ULTHEAFYOOPTTB-UHFFFAOYSA-N 0.000 claims description 8
- GPYLCFQEKPUWLD-UHFFFAOYSA-N 1h-benzo[cd]indol-2-one Chemical compound C1=CC(C(=O)N2)=C3C2=CC=CC3=C1 GPYLCFQEKPUWLD-UHFFFAOYSA-N 0.000 claims description 8
- GQWAOUOHRMHSHL-UHFFFAOYSA-N 4-ethenyl-n,n-dimethylaniline Chemical compound CN(C)C1=CC=C(C=C)C=C1 GQWAOUOHRMHSHL-UHFFFAOYSA-N 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 claims description 8
- 239000012074 organic phase Substances 0.000 claims description 8
- 239000012071 phase Substances 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- 239000012043 crude product Substances 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 claims description 5
- 229910052808 lithium carbonate Inorganic materials 0.000 claims description 5
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 4
- CQCAYWAIRTVXIY-UHFFFAOYSA-N 2-(triphenyl-$l^{5}-phosphanylidene)acetaldehyde Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC=O)C1=CC=CC=C1 CQCAYWAIRTVXIY-UHFFFAOYSA-N 0.000 claims description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- CCERQOYLJJULMD-UHFFFAOYSA-M magnesium;carbanide;chloride Chemical compound [CH3-].[Mg+2].[Cl-] CCERQOYLJJULMD-UHFFFAOYSA-M 0.000 claims description 3
- 239000003208 petroleum Substances 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 230000036632 reaction speed Effects 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 125000005489 p-toluenesulfonic acid group Chemical group 0.000 claims description 2
- BTOVVHWKPVSLBI-UHFFFAOYSA-N 2-methylprop-1-enylbenzene Chemical group CC(C)=CC1=CC=CC=C1 BTOVVHWKPVSLBI-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 230000008020 evaporation Effects 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 238000006862 quantum yield reaction Methods 0.000 abstract description 10
- 238000000799 fluorescence microscopy Methods 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract description 8
- 238000012986 modification Methods 0.000 abstract description 7
- 230000004048 modification Effects 0.000 abstract description 7
- 238000005516 engineering process Methods 0.000 abstract description 6
- 239000007850 fluorescent dye Substances 0.000 abstract description 4
- 238000001308 synthesis method Methods 0.000 abstract description 2
- 238000006257 total synthesis reaction Methods 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000013067 intermediate product Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- -1 small molecule compounds Chemical class 0.000 description 2
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 2
- RILZRCJGXSFXNE-UHFFFAOYSA-N 2-[4-(trifluoromethoxy)phenyl]ethanol Chemical compound OCCC1=CC=C(OC(F)(F)F)C=C1 RILZRCJGXSFXNE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/0075—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain being part of an heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/10—The polymethine chain containing an even number of >CH- groups
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1096—Heterocyclic compounds characterised by ligands containing other heteroatoms
Definitions
- the invention provides a method for preparing fluorescent small molecules in the second near-infrared region, and relates to the fields of chemical sensing technology and fluorescence imaging.
- Fluorescence microscopy imaging technology is one of the most widely used technologies in current optical imaging technology, and near-infrared fluorescence in vivo imaging technology, which is also fluorescence imaging, is also attracting more and more attention in the field of biomedicine.
- Traditional fluorescence imaging is mainly concentrated in the near-infrared region (NIR-I), the fluorescence emission wavelength range is 650-950nm, the wavelength is relatively short ( ⁇ 1000nm), and the photon penetration depth is poor, which has become the main obstacle for the application of in vivo biomedical fluorescence imaging .
- the wavelength is in the range of 1000-1700nm, that is, the near-infrared region II (NIR-II) fluorescence imaging
- the light can penetrate deeper biological tissues, and the scattered light in this wavelength window is less.
- NIR-II light has the advantages of deeper penetration into biological tissue (about 5-20mm), weakened background autofluorescence, and improved signal-to-noise ratio
- the emerging fluorescence imaging in the NIR-II region has attracted more and more attention.
- the probes in NIR-II fluorescence imaging mainly include the following categories: rare earth elements, nanomaterials, carbon nanotubes, quantum dots, organic molecular polymers, and organic small molecule compounds.
- organic near-infrared second-region fluorescent small molecules are mainly divided into three categories.
- the first type is a near-infrared second-region fluorescent small molecule with a benzobisthiadiazole structure as the main body. This probe has a high fluorescence quantum yield, but the probe The synthesis steps are cumbersome, and the synthesis requires the use of highly toxic tin reagents.
- the second type is a near-infrared second-region fluorescent small molecule with polymethyl as the main body. It is mainly an extension of the near-infrared first-region cyanine dye probe and replaces the electron-donating group. decomposition, and the quantum yield is low.
- the third category is to study cyanine dyes, which have fluorescence tailing at 1000-1200nm, and the fluorescence quantum yield is extremely low, which requires high requirements for testing instruments.
- the preparation of fluorescent small molecules in the second near-infrared region with high fluorescence quantum yield, simple synthesis process, stable chemical structure, safety to the human body and easy modification can further expand the library of small fluorescent molecules in the second region of near-infrared and make up for other types of near-infrared fluorescent small molecules.
- the small fluorescent molecules in the second infrared region are insufficient in actual use, and have high scientific research and clinical application value.
- the object of the present invention is to provide a method for preparing a naphthalimide-based near-infrared second region fluorescent small molecule.
- the organic fluorescent molecule has the advantages of simple synthesis, stable chemical structure, easy modification and high fluorescence quantum yield.
- a naphthalimide-based near-infrared second-region fluorescent small molecule mainly using naphthalimide salt as a strong electron acceptor, using dioxythiophene as a ⁇ bridge to increase the stability of the chemical structure of the fluorescent small molecule, and using N,
- the N-dimethylstyrene structure is used as an electron donor to construct a near-infrared two-region fluorescent small molecule probe with a D- ⁇ -A architecture.
- Described dioxythiophene structure F2 is:
- the N,N-dimethylstyrene structure F3 is:
- the fluorescent small molecule F4 in the second near-infrared region is:
- the bromine group is used as the electron donor, which is easy to further modify the probe, and the dioxythiophene heterocycle is easy to stabilize the structure of small molecules.
- a method for preparing fluorescent small molecules in the second near-infrared region comprising the following process steps:
- step A the temperature is raised to 138-140° C. under stirring.
- the stabilizer is hydrochloric acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, p-toluenesulfonic acid or a mixture of two or more, through the addition of the stabilizer, greatly inhibited by-products formation, increasing the yield of the target product.
- the stabilizer is p-toluenesulfonic acid.
- step D the mixed solution is heated to 135-138°C.
- the first catalyst is one or a mixture of two or more of triphenylphosphine, triethylamine, and tetramethylammonium chloride.
- the first catalyst is a composite catalyst formed by mixing triphenylphosphine and tetramethylammonium chloride.
- the catalyst two is one or a mixture of two or more of methylamine, dimethylamine, trimethylamine, triethylamine, lithium carbonate, and potassium carbonate.
- the second catalyst is lithium carbonate.
- the present invention greatly simplifies the technical synthesis process of fluorescent small molecules in the second near-infrared region, shortens the product preparation time, and improves the product yield.
- the chemical structure of the formed near-infrared second-region fluorescent small molecule is stable.
- the electron donor uses a bromine group, which is easy to further modify the probe.
- the dioxythiophene heterocycle tends to stabilize the structure of small molecules.
- the fluorescence quantum yield of the fluorescent probe formed in the present invention is high.
- the fluorescent probe of the present invention is safe to the human body.
- step A of the present invention suppresses the generation of by-products and improves the yield of the target product.
- the composite catalyst used in the step D of the present invention greatly reduces the reaction temperature and shortens the reaction time, improves the product yield, and greatly saves energy consumption and raw material consumption.
- this near-infrared second-region fluorescent small molecule has the advantages of simple synthesis steps, easy modification, stable chemical structure and high fluorescence quantum yield. It has great potential in the field of tumor surgical navigation imaging and medical cell labeling. Huge potential for development.
- Figure 1 is a synthetic flow chart for preparing fluorescent molecules in the second near-infrared region.
- Figure 2 is the characterization diagram of the hydrogen nuclear magnetic resonance spectrum of the fluorescent molecule in the second near-infrared region
- Figure 3 is a mass spectrometry representation of fluorescent molecules in the second near-infrared region.
- Fig. 4 is a graph showing the fluorescence performance of the prepared near-infrared second region fluorescent molecule.
- a method for preparing a fluorescent small molecule in the second near-infrared region comprising the following steps:
- N,N-dimethylformamide 200g add catalyst triphenylphosphine 18.5g and tetramethylammonium chloride 0.5g, add 4-vinyl-N, N-dimethylaniline F3 ( 5g, 34mmol) and dioxythiophene F2 (6.5g, 24mmol), then the mixed solution was heated to 125 ° C, and stirred for 20 hours under nitrogen protection conditions, after the reaction, the reaction solution was extracted with water and dichloromethane, separated Separate phases, and the combined organic phases were dried with Na 2 SO 4 , and the solvent was evaporated under reduced pressure, and the bottom liquid was purified by column chromatography to obtain 3.8 g (94.3%) of the intermediate diM2 product, and the yield was 40.8% .
- FIG. 2 it is the H NMR spectrum characterization diagram of the fluorescent molecule F1 in the second near-infrared region obtained in this embodiment.
- FIG. 3 is a mass spectrum characterization diagram of the near-infrared two-region fluorescent molecule F1 obtained in this embodiment.
- Fig. 4 it is the fluorescence performance diagram of the fluorescent molecule F1 obtained in this embodiment.
- the wavelength is 900nm
- the absorptivity is 0.45
- the absorptivity reaches the maximum value.
- the wavelength is 1100nm
- the light intensity is 4000. The light intensity reaches its maximum value.
- a method for preparing fluorescent small molecules in the second near-infrared region comprising the following steps:
- a method for preparing fluorescent small molecules in the second near-infrared region comprising the following steps:
- a method for preparing fluorescent small molecules in the second near-infrared region comprising the following steps:
- a method for preparing fluorescent small molecules in the second near-infrared region comprising the following steps:
- a method for preparing fluorescent small molecules in the second near-infrared region comprising the following steps:
- N,N-dimethylformamide 200g add catalyst triphenylphosphine 18.5g and tetramethylammonium chloride 0.5g, add 4-vinyl-N, N-dimethylaniline F3 ( 5g, 34mmol) and F2 (6.5g, 24mmol), then the mixed solution was heated to 135 ° C, and stirred for 15 hours under nitrogen protection conditions, after the reaction, the reaction solution was extracted with water and dichloromethane, and the phases were separated. The combined organic phases were dried with Na 2 SO 4 , and the solvent was evaporated under reduced pressure, and the bottom liquid was purified by column chromatography to obtain 3.87 g (94.7%) of intermediate diM2 with a yield of 41.6%.
- N,N-dimethylformamide 200g add catalyst triphenylphosphine 18.5g and tetramethylammonium chloride 0.5g, add 4-vinyl-N, N-dimethylaniline F3 ( 5g, 34mmol) and F2 (6.5g, 24mmol), then the mixed solution was heated to 150 ° C, and stirred for 12 hours under nitrogen protection conditions, after the reaction, the reaction solution was extracted with water and methylene chloride, and the phases were separated. The combined organic phases were dried with Na 2 SO 4 , and the solvent was evaporated under reduced pressure, and the bottom liquid was purified by column chromatography to obtain 3.72 g (94.6%) of intermediate diM2 with a yield of 40.0%.
- N, N-dimethylformamide 200g add catalyst tetramethylammonium chloride 1.7g, add 4-vinyl-N, N-dimethylaniline F3 (5g, 34mmol) and F2 ( 6.5g, 24mmol), then the mixed solution was heated to 135°C, and stirred and reacted for 15 hours under nitrogen protection conditions, after the reaction was finished, the reaction solution was extracted with water and methylene chloride, each phase was separated, and the combined organic phase was used Na 2 SO 4 was dried, and the solvent was evaporated under reduced pressure, and the bottom liquid was purified by column chromatography to obtain 3.45 g (94.2%) of intermediate diM2, with a yield of 37.02%.
- the near-infrared two-region fluorescent molecule of the present invention has the advantages of simple synthesis method, easy modification, stable structure and high fluorescence quantum yield, etc. Further modify it to develop a new type of near-infrared second-region probe with better water solubility and optical properties, and provide a new probe family for the research of near-infrared second-region probes in the field of tumor surgical navigation imaging and medical cell labeling .
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
提供一种近红外二区荧光小分子的制备方法,利用有机全合成的方法构建制备了一种新型结构荧光探针小分子,属于化学传感技术及荧光成像领域。这种近红外二区荧光小分子相对于目前研究较多的苯并双噻二唑结构的荧光探针合成方法简单、易于修饰、结构稳定和荧光量子产率高等优点。
Description
本发明提供一种近红外二区荧光小分子的制备方法,涉及化学传感技术及荧光成像领域。
荧光显微成像技术是当前光学成像技术中最为广泛使用的技术之一,同为荧光成像的近红外荧光活体成像技术在生物医学领域也越来越受关注。传统的荧光成像主要集中在近红外一区(NIR-I),荧光发射波长范围650—950nm,波长较短(<1000nm),光子穿透深度较差,成为活体生物医学荧光成像应用的主要障碍。与可见光和NIR-I光相比,波长处在1000—1700nm,即近红外二区(NIR-II)荧光成像,光可以穿透更深的生物组织,在这个波长窗口的散射光更少。由于NIR-II光具有生物组织穿透更深(约5—20mm)、背景自发荧光减弱和信噪比提高等优势,NIR-II区域新出现的荧光成像越来越受到关注。NIR-II荧光成像中的探针主要有以下几类:稀土元素、纳米材料、碳纳米管、量子点、有机分子聚合物以及有机小分子化合物。
通常,有机近红外二区荧光小分子主要分为三类,第一类是以苯并双噻二唑结构为主体的近红外二区荧光小分子,该探针荧光量子产率高,但探针合成步骤繁琐,合成需要用到毒性较大的锡试剂。第二类是以聚甲基为主体的近红外二区荧光小分子,主要是对近红外一区菁染料探针的延伸,将供电子基团进行替换,但其稳定性差,极易在光照下分解,且量子产率较低。第三类是研究菁染料,在1000-1200nm处有荧光拖尾,荧光量子产率极低,对测试仪器的要求很高。
由此可见,制备高荧光量子产率、合成工艺简单、化学结构稳定、对人体安全且易于修饰的近红外二区荧光小分子,从而进一步扩充近红外二区荧光小分子库,弥补其他类近红外二区荧光小分子在实际使用中的不足,具有很高的科研及临床应用价值。
发明内容
本发明的目的在于,提供了一种萘酰亚胺类近红外二区荧光小分子的制备方法。这种有机荧光分子合成简单、化学结构稳定且易于修饰和荧光量子产率高。
为了实现上述发明的目的,其具体的技术方案如下:
一种萘酰亚胺类近红外二区荧光小分子,主要是以萘酰亚胺盐作为强电子受体,以二氧噻吩作为π桥以增加荧光小分子化学结构的稳定性,以N,N-二甲基苯乙烯结构作为电子供体,构建具备D-π-A体系结构的近红外二区荧光小分子探针,这种近红外二区荧光分子具备合成简单、化学结构稳定且易于修饰和荧光量子产率高等优点,在肿瘤手术导航成 像及医学细胞标记领域具有巨大的发展潜力。所述的萘酰亚胺盐F1为:
所述的二氧噻吩结构F2为:
所述的N,N-二甲基苯乙烯结构F3为:
所述近红外二区荧光小分子F4为:
电子供体用溴基团,易于进一步对探针进行修饰,二氧噻吩杂环易于稳定小分子的结构。
一种近红外二区荧光小分子的制备方法,包括以下工艺步骤:
A、中间体一M1的合成
在带搅拌的反应釜中依次加入称量的N,N-二甲基甲酰胺、1,8-萘内酰亚胺、无水氢氧化锂,搅拌下加热升温至125~150℃,氮气置换反应体系中的空气,氮气保护下滴加称量的1,4-二溴丁烷,保温反应30~100分钟,随后,加入稳定剂,搅拌15~60分钟,减压精馏,釜底液中加入乙醇,结晶,过滤干燥得到中间体产品M1。
B、萘酰亚胺盐F1的合成
将中间体一M1加入四氢呋喃中,搅拌下氮气保护下加热至52~58℃,滴加甲基氯化镁溶液,滴加完毕,升温至62~66℃,保温反应0.5~2.5小时,蒸馏回收溶剂,向釜底液中加入适量水,室温下缓慢滴加质量百分含量为20%的氟硼酸溶液,控制反应速度,待滴加完毕,维持搅拌0.5~1小时,抽滤得萘酰亚胺盐F1产品。
C、二氧噻吩F2的合成
将5-溴-2-(3,4-乙烯基双氧噻吩)甲醛和(甲酰基亚甲基)三苯基膦在甲苯的溶液中混合并加热至回流,维持反应12~18小时。减压蒸发溶剂得到粗产物,并将粗产物在硅胶柱上纯化,用石油醚/二氯甲烷混合物作为洗脱剂,得到白色粉末状二氧噻吩F2产品。
D、中间体二M2的合成
向N,N-二甲基甲酰胺中添加计量的催化剂一,搅拌下依次加入计量的4-乙烯基-N,N-二甲基苯胺F3和二氧噻吩F2,然后将混合溶液加热至125~150℃,并在氮气保护条件下搅拌反应12~20小时,反应结束后将反应溶液用水和二氯甲烷萃取,分离各相,并将合并的有机相用Na
2SO
4干燥,并将溶剂减压蒸发,残余物通过柱色谱法纯化,得到中间体二M2。
E、近红外二区荧光小分子F4的合成
将中间体二M2和萘酰亚胺盐F1混合于乙醇中,加入适量催化剂二,在氮气保护下搅拌4~12小时,反应结束后将溶剂减压蒸发,残余物通过柱色谱法纯化,得到终产物为近红外二区荧光小分子F4。
优选的,步骤A中,搅拌下加热升温至138~140℃。
优选的,在步骤A中,所述稳定剂为盐酸、硫酸、磷酸、甲酸、乙酸、对甲苯磺酸一种或者两种以上的混合物,通过所述稳定剂的加入,大大抑制了副产物的生成,提高了目标产物的产率。
优选的,在步骤A中,所述稳定剂为对甲苯磺酸。
优选的,在步骤D中将混合溶液加热至135~138℃。
优选的,步骤D中,所述的催化剂一为三苯基膦、三乙胺、四甲基氯化铵中的一种或两种以上的混合物。
优选的,在步骤D中,所述的催化剂一为三苯基膦和四甲基氯化铵混合形成的复合催化剂。
优选的,步骤E中,所述的催化剂二为甲胺、二甲胺、三甲胺、三乙胺、碳酸锂、碳酸钾中的一种或两种以上的混合物。
优选的,在步骤E中,所述催化剂二为碳酸锂。
本发明带来的有益技术效果:
1、本发明大大简化了近红外二区荧光小分子的工艺合成过程,缩短了产品制备时间,提高了产品收率。
2、通过分子构建,形成的近红外二区荧光小分子的化学结构稳定,近红外二区荧光小分子结构中,电子供体用溴基团,易于进一步对探针进行修饰。二氧噻吩杂环易于稳定小分子的结构。
3、本发明形成的荧光探针的荧光量子产率高。
4、本发明的荧光探针对人体安全。
5、本发明步骤A中稳定剂的加入,抑制了副产物的生成,提高了目标产物的产率。
6、本发明步骤D中使用的复合催化剂,大大降低反应温度、缩短反应时间的同时,提高了产品收率,大大节约能耗及原材料消耗。
7、利用有机全合成的方法制备,这种近红外二区荧光小分子具有了合成步骤简单,易于修饰,化学结构稳定且荧光量子产率高等优点,在肿瘤手术导航成像及医学细胞标记领域具有巨大的发展潜力。
图1是制备近红外二区荧光分子的合成流程图。
图2是近红外二区荧光分子核磁共振氢谱表征图
图3是近红外二区荧光分子质谱表征图。
图4是制备近红外二区荧光分子荧光性能图。
为了使本领域的技术人员更好地理解本发明的技术方案,下面结合附图与具体实施方式对本发明作进一步的详细说明。
实施例1
一种近红外二区荧光小分子的制备方法,如图1所示,包括以下步骤:
A、中间体一M1的合成
在带搅拌的反应釜中依次加入N,N-二甲基甲酰胺200g、1,8-萘内酰亚胺10g(59.1mmol)、无水氢氧化锂0.14g,搅拌下加热升温至125℃,氮气置换反应体系中的空气,氮气保护下滴加1,4-二溴丁烷20g(92.5mmol),保温反应30~100分钟,随后,加入稳定剂对甲苯磺酸1.2g,继续搅拌15~60分钟,减压精馏,分离釜底液中加入乙醇,结晶,过滤干燥得到中间体一M1共计16.2g(98.50%),产率为92.07%。
B、萘酰亚胺盐F1的合成
将中间体一M1(12g,40mmol)加入无水的四氢呋喃中,氮气保护下搅拌加热至52℃,滴加甲基氯化镁溶液,滴加完毕,升温至62℃,保温反应2小时,蒸馏回收溶剂,向釜底液中加入水50g,室温下缓慢滴加质量百分含量为20%的氟硼酸溶液17.6g,控制反应速度,待滴加完毕,维持搅拌0.5~1小时,抽滤得萘酰亚胺盐F1共计10.6g(98.2%),产率为90%。
C、二氧噻吩F2的合成
将5-溴-2-(3,4-乙烯基双氧噻吩)甲醛10g(40.1mmol)和(甲酰基亚甲基)三苯基膦10g(52.3mmol)在无水甲苯的溶液中混合并加热至回流,维持反应12小时。减压蒸发溶剂,并将粗产物在硅胶柱上纯化,用石油醚/二氯甲烷(2:1,v/v)混合物作为洗脱剂,得到白色粉末状二氧噻吩F2产品8.8g(95%),产率为80%。
D、中间体二M2的合成
向N,N-二甲基甲酰胺200g中,添加催化剂三苯基膦18.5g和四甲基氯化铵0.5g,搅拌下依次加入4-乙烯基-N,N-二甲基苯胺F3(5g,34mmol)和二氧噻吩F2(6.5g,24mmol),然后将混合溶液加热至125℃,并在氮气保护条件下搅拌反应20小时,反应结束后将反应溶液用水和二氯甲烷萃取,分离各相,并将合并的有机相用Na
2SO
4干燥,并将溶剂减压蒸发,釜底液通过柱色谱法纯化,得到中间体二M2产品3.8g(94.3%),收率为40.8%。
E、近红外二区荧光小分子F4的合成
将上述中间体二M2产品3.8g和萘酰亚胺盐F1产品2g混合于30ml乙醇中,加入碳酸锂催化剂50mg,在氮气保护下搅拌6小时,反应结束后将溶剂减压蒸发,残余物通过柱色谱法纯化,二氯甲烷/甲醇(2:1,v/v)的混合液作为洗脱剂,得到终产物近红外二区荧光小分子F4产品3g(97%),收率为80%。
如图2所示,为本实施例得到的近红外二区荧光分子F1的核磁共振氢谱表征图。图3所示,为本实施例得到的近红外二区荧光分子F1的质谱表征图。图4所示,为本实施例得到的近红外二区荧光分子F1的荧光性能图,当波长900nm的时候,吸收率为0.45,吸收率达到最大值,波长1100nm的时候,光强为4000,光强达到最大值。
实施例2
一种近红外二区荧光小分子的制备方法,包括以下步骤:
A、中间体一M1的合成
在带搅拌的反应釜中依次加入N,N-二甲基甲酰胺200g、1,8-萘内酰亚胺10.2g(59.1mmol)、无水氢氧化锂0.14g,搅拌下加热升温至150℃,氮气置换反应体系中的空气,氮气保护下滴加1,4-二溴丁烷20.2g(92.5mmol),保温反应30~100分钟,随后,加入稳定剂对甲苯磺酸1.2g,继续搅拌15~60分钟,减压精馏,分离釜底液中加入乙醇,结晶,过滤干燥得到中间体产品M1共计16.08g(98.32%),产率为91.32%。
其余步骤按实施例1施行。
实施例3
一种近红外二区荧光小分子的制备方法,包括以下步骤:
A、中间体一M1的合成
在带搅拌的反应釜中依次加入N,N-二甲基甲酰胺200g、1,8-萘内酰亚胺10.2g(59.1mmol)、无水氢氧化锂0.14g,搅拌下加热升温至138℃,氮气置换反应体系中的空气,氮气保护下滴加1,4-二溴丁烷20.2g(92.5mmol),保温反应30~100分钟,随后,加入稳定剂对甲苯磺酸1.2g,继续搅拌15~60分钟,减压精馏,分离釜底液中加入乙醇,结晶,过滤干燥得到中间体产品M1共计16.35g(98.39%),产率为92.71%。
其余步骤按实施例1施行。
实施例4
一种近红外二区荧光小分子的制备方法,包括以下步骤:
A、中间体一M1的合成
在带搅拌的反应釜中依次加入N,N-二甲基甲酰胺200g、1,8-萘内酰亚胺10.2g(59.1mmol)、无水氢氧化锂0.14g,搅拌下加热升温至138℃,氮气置换反应体系中的空气,氮气保护下滴加1,4-二溴丁烷20.2g(92.5mmol),保温反应30~100分钟,随后,加入稳定剂甲酸0.42g,继续搅拌15~60分钟,减压精馏,分离釜底液中加入乙醇,结晶,过滤干燥得到中间体产品M1共计15.7g(98.18%),产率为89.01%。
其余步骤按实施例1施行。
实施例5
一种近红外二区荧光小分子的制备方法,包括以下步骤:
A、中间体一M1的合成
在带搅拌的反应釜中依次加入N,N-二甲基甲酰胺200g、1,8-萘内酰亚胺10.2g(59.1mmol)、无水氢氧化锂0.14g,搅拌下加热升温至138℃,氮气置换反应体系中的空气,氮气保护下滴加1,4-二溴丁烷20.2g(92.5mmol),保温反应30~100分钟,随后,加入稳定剂盐酸0.25g,继续搅拌15~60分钟,减压精馏,分离釜底液中加入乙醇,结晶,过滤干燥得到中间体产品M1共计15.3g(98.23%),产率为86.74%。
其余步骤按实施例1施行。
实施例6
一种近红外二区荧光小分子的制备方法,包括以下步骤:
A、中间体一M1的合成
在带搅拌的反应釜中依次加入N,N-二甲基甲酰胺200g、1,8-萘内酰亚胺10.2g(59.1mmol)、无水氢氧化锂0.14g,搅拌下加热升温至138℃,氮气置换反应体系中的空气,氮气保护下滴加1,4-二溴丁烷20.2g(92.5mmol),保温反应30~100分钟,随后,加入稳定剂盐酸0.25g,继续搅拌15~60分钟,减压精馏,分离釜底液中加入乙醇,结晶,过滤干燥得到中间体产品M1共计15.3g(98.23%),产率为86.74%。
其余步骤按实施例1施行。
实施例7
基于实施例3,本发明中:
D、中间体二M2的合成
向N,N-二甲基甲酰胺200g中,添加催化剂三苯基膦18.5g和四甲基氯化铵0.5g,搅拌下依次加入4-乙烯基-N,N-二甲基苯胺F3(5g,34mmol)和F2(6.5g,24mmol),然后将混合溶液加热至135℃,并在氮气保护条件下搅拌反应15小时,反应结束后将反应溶液用水和二氯甲烷萃取,分离各相,并将合并的有机相用Na
2SO
4干燥,并将溶剂减压蒸发,釜底液通过柱色谱法纯化,得到中间体二M2产品3.87g(94.7%),收率为41.6%。
实施例8
基于实施例3,本发明中:
D、中间体二M2的合成
向N,N-二甲基甲酰胺200g中,添加催化剂三苯基膦18.5g和四甲基氯化铵0.5g,搅拌下依次加入4-乙烯基-N,N-二甲基苯胺F3(5g,34mmol)和F2(6.5g,24mmol),然后将混合溶液加热至150℃,并在氮气保护条件下搅拌反应12小时,反应结束后将反应溶液用水和二氯甲烷萃取,分离各相,并将合并的有机相用Na
2SO
4干燥,并将溶剂减压蒸发,釜底液通过柱色谱法纯化,得到中间体二M2产品3.72g(94.6%),收率为40.0%。
实施例9
基于实施例3,本发明中:
D、中间体二M2的合成
向N,N-二甲基甲酰胺200g中,添加催化剂三苯基膦18.5g和三乙胺0.45g,搅拌下依次加入4-乙烯基-N,N-二甲基苯胺F3(5g,34mmol)和F2(6.5g,24mmol),然后将混合溶液加热至135℃,并在氮气保护条件下搅拌反应15小时,反应结束后将反应溶液用水和二氯甲烷萃取,分离各相,并将合并的有机相用Na
2SO
4干燥,并将溶剂减压蒸发,釜底液通过柱色谱法纯化,得到中间体二M2产品3.5g(94.6%),收率为37.6%。
实施例10
基于实施例3,本发明中:
D、中间体二M2的合成
向N,N-二甲基甲酰胺200g中,添加催化剂三苯基膦19.0g,搅拌下依次加入4-乙烯基-N,N-二甲基苯胺F3(5g,34mmol)和F2(6.5g,24mmol),然后将混合溶液加热至135℃,并在氮气保护条件下搅拌反应15小时,反应结束后将反应溶液用水和二氯甲烷萃取,分离各相,并将合并的有机相用Na
2SO
4干燥,并将溶剂减压蒸发,釜底液通过柱色谱法纯化,得到中间体二M2产品3.45g(94.2%),收率为37.02%。
实施例11
基于实施例3,本发明中:
D、中间体二M2的合成
向N,N-二甲基甲酰胺200g中,添加催化剂四甲基氯化铵1.7g,搅拌下依次加入4-乙烯基-N,N-二甲基苯胺F3(5g,34mmol)和F2(6.5g,24mmol),然后将混合溶液加热至135℃,并在氮气保护条件下搅拌反应15小时,反应结束后将反应溶液用水和二氯甲烷萃取,分离各相,并将合并的有机相用Na
2SO
4干燥,并将溶剂减压蒸发,釜底液通过柱色谱法纯化,得到中间体二M2产品3.45g(94.2%),收率为37.02%。
实施例12
基于实施例3,本发明中:
E、近红外二区荧光小分子F4的合成
将中间体二M2产品3.8g和萘酰亚胺盐F1产品2g混合于30ml乙醇中,加入碳酸钾催化剂87.5mg,在氮气保护下搅拌10小时,反应结束后将溶剂减压蒸发,残余物通过柱色谱法纯化,二氯甲烷/甲醇(2:1,v/v)的混合液作为洗脱剂,得到终产物近红外二区荧光小分子F4产品2.7g(97.3%),收率为72%。
实施例13
基于实施例3,本发明中:
E、近红外二区荧光小分子F4的合成
将中间体二M2产品3.8g和萘酰亚胺盐F1产品2g混合于30ml乙醇中,加入三乙胺催化剂64.5mg,在氮气保护下搅拌10小时,反应结束后将溶剂减压蒸发,残余物通过柱色谱法纯化,二氯甲烷/甲醇(2:1,v/v)的混合液作为洗脱剂,得到终产物近红外二区荧光小分子F4产品2.48g(97.03%),收率为65.9%。
本发明这种近红外二区荧光分子相对于目前研究较多的苯并双噻二唑结构的近红外二区荧光探针合成方法简单、易于修饰、结构稳定和荧光量子产率高等优点,有望将其进一步改性,开发水溶性和光学性质更加优异的新型近红外二区探针,为近红外二区探针在肿瘤手术导航成像及医学细胞标记领域的研究提供一种新的探针家族。
以上所述仅是本实用新型的优选实施方式,应当指出:对于本技术领域的普通技术人员来说,在不脱离本实用新型原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本实用新型的保护范围。
Claims (9)
- 一种近红外二区荧光小分子的制备方法,其特征在于:所述近红外二区荧光小分子以萘酰亚胺盐作为强电子受体,以二氧噻吩作为π桥,以N,N-二甲基苯乙烯结构作为电子供体,构建具备D-π-A体系结构的近红外二区荧光小分子,所述的萘酰亚胺盐F1为:所述的二氧噻吩F2结构为:所述的N,N-二甲基苯乙烯F3结构为:所述近红外二区荧光小分子F4结构为:所述近红外二区荧光小分子的制备方法包括以下步骤:A、中间体一M1的合成在带搅拌的反应釜中依次加入N,N-二甲基甲酰胺、1,8-萘内酰亚胺、无水氢氧化锂,搅拌下加热升温至125~150℃,氮气置换反应体系中的空气,氮气保护下滴加1,4-二溴丁烷,保温反应30~100分钟,随后,加入稳定剂,搅拌15~60分钟,减压精馏,釜底液中加入乙醇,结晶,过滤干燥得到中间体一M1;B、萘酰亚胺盐F1的合成将中间体一M1加入四氢呋喃中,搅拌下氮气保护下加热至52~58℃,滴加甲基氯化镁溶液,滴加完毕,升温至62~66℃,保温反应0.5~2.5小时,蒸馏回收溶剂,向釜底液中加入适量水,室温下缓慢滴加质量百分含量为20%的氟硼酸溶液,控制反应速度,待滴加完毕,维持搅拌0.5~1小时,抽滤得萘酰亚胺盐F1;C、二氧噻吩F2的合成将5-溴-2-(3,4-乙烯基双氧噻吩)甲醛和(甲酰基亚甲基)三苯基膦在甲苯的溶液中混合并加热至回流,维持反应12~18小时,减压蒸发溶剂得到粗产物,并将粗产物在硅胶柱上纯化,用石油醚/二氯甲烷混合物作为洗脱剂,得到白色粉末状二氧噻吩F2;D、中间体二M2的合成向N,N-二甲基甲酰胺中添加计量的催化剂一,搅拌下依次加入4-乙烯基-N,N-二甲基苯胺F3和二氧噻吩F2,然后将混合溶液加热至125~150℃,并在氮气保护条件下搅拌反应12~20小时,反应结束后将反应溶液用水和二氯甲烷萃取,分离各相,并将合并的有机相用Na 2SO 4干燥,并将溶剂减压蒸发,残余物通过柱色谱法纯化,得到中间体二M2;E、近红外二区荧光小分子F4的合成将中间体二M2和萘酰亚胺盐F1混合于乙醇中,加入催化剂二,在氮气保护下搅拌4~12小时,反应结束后将溶剂减压蒸发,残余物通过柱色谱法纯化,得到终产物为近红外二区荧光小分子F4。
- 根据权利要求1所述的一种近红外二区荧光小分子的制备方法,其特征在于:步骤A中,搅拌下加热升温至138~140℃。
- 根据权利要求1或2所述的一种近红外二区荧光小分子的制备方法,其特征在于:在步骤A中,所述稳定剂为盐酸、硫酸、磷酸、甲酸、乙酸、对甲苯磺酸一种或者两种以上的混合物。
- 根据权利要求3所述的一种近红外二区荧光小分子的制备方法,其特征在于:在步骤A中,所述稳定剂为对甲苯磺酸。
- 根据权利要求1所述的一种近红外二区荧光小分子的制备方法,其特征在于:在步骤D中将混合溶液加热至135~138℃。
- 根据权利要求1所述的一种近红外二区荧光小分子的制备方法,其特征在于:步骤D中,所述的催化剂一为三苯基膦、三乙胺、四甲基氯化铵中的一种或两种以上的混合物。
- 根据权利要求1所述的一种近红外二区荧光小分子的制备方法,其特征在于:在步骤D中,所述的催化剂一为三苯基膦和四甲基氯化铵混合形成的复合催化剂。
- 根据权利要求1所述的一种近红外二区荧光小分子的制备方法,其特征在于:步骤E中, 所述的催化剂二为甲胺、二甲胺、三甲胺、三乙胺、碳酸锂、碳酸钾中的一种或两种以上的混合物。
- 根据权利要求1所述的一种近红外二区荧光小分子的制备方法,其特征在于:在步骤E中,所述催化剂二为碳酸锂。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP22754273.5A EP4183791A4 (en) | 2021-08-03 | 2022-05-09 | METHOD FOR PREPARING SECOND NEAR INFRARED REGION FLUORESCENT MICROMOLECULES |
US17/907,972 US20240199633A1 (en) | 2021-08-03 | 2022-05-09 | Method for preparing near-infrared region ii fluorescent small molecule |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110886270.7A CN113461707B (zh) | 2021-08-03 | 2021-08-03 | 一种近红外二区荧光小分子的制备方法 |
CN202110886270.7 | 2021-08-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023010925A1 true WO2023010925A1 (zh) | 2023-02-09 |
Family
ID=77883810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/091633 WO2023010925A1 (zh) | 2021-08-03 | 2022-05-09 | 一种近红外二区荧光小分子的制备方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20240199633A1 (zh) |
EP (1) | EP4183791A4 (zh) |
CN (1) | CN113461707B (zh) |
WO (1) | WO2023010925A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113461707B (zh) * | 2021-08-03 | 2022-04-12 | 南京诺源医疗器械有限公司 | 一种近红外二区荧光小分子的制备方法 |
CN114539232B (zh) * | 2022-01-26 | 2023-04-28 | 深圳大学 | 一种pH可逆激活近红外二区聚集诱导发光I型光敏剂及其应用 |
CN114634499B (zh) * | 2022-02-14 | 2023-06-13 | 深圳大学 | 一种聚集诱导发光材料及其制备方法与应用 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108440986A (zh) * | 2018-03-06 | 2018-08-24 | 复旦大学 | 近红外第二窗口激发/发射的荧光染料及其制备方法和应用 |
CN109665987A (zh) * | 2018-12-28 | 2019-04-23 | 河南大学 | 萘内酰亚胺-多胺缀合物及其制备方法和用途 |
US20200183245A1 (en) * | 2018-09-17 | 2020-06-11 | Lightwave Logic, Inc. | Electro-optic polymer devices having high performance claddings, and methods of preparing the same |
CN111334066A (zh) * | 2018-12-18 | 2020-06-26 | 中国科学院大连化学物理研究所 | 一类640nm激发的近红外荧光染料及其制备方法 |
CN111961040A (zh) * | 2020-09-03 | 2020-11-20 | 山东大学 | 一种基于咔唑基的有机双杂环近红外荧光探针及其制备方法与应用 |
CN112898282A (zh) * | 2021-01-25 | 2021-06-04 | 常州大学 | 一类D-π-A型AIE-TADF近红外发光材料及其制备方法与应用 |
CN113429421A (zh) * | 2021-07-19 | 2021-09-24 | 南京诺源医疗器械有限公司 | 一种有机小分子荧光探针的制备方法 |
CN113461707A (zh) * | 2021-08-03 | 2021-10-01 | 南京诺源医疗器械有限公司 | 一种近红外二区荧光小分子的制备方法 |
-
2021
- 2021-08-03 CN CN202110886270.7A patent/CN113461707B/zh active Active
-
2022
- 2022-05-09 WO PCT/CN2022/091633 patent/WO2023010925A1/zh active Application Filing
- 2022-05-09 EP EP22754273.5A patent/EP4183791A4/en active Pending
- 2022-05-09 US US17/907,972 patent/US20240199633A1/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108440986A (zh) * | 2018-03-06 | 2018-08-24 | 复旦大学 | 近红外第二窗口激发/发射的荧光染料及其制备方法和应用 |
US20200183245A1 (en) * | 2018-09-17 | 2020-06-11 | Lightwave Logic, Inc. | Electro-optic polymer devices having high performance claddings, and methods of preparing the same |
CN111334066A (zh) * | 2018-12-18 | 2020-06-26 | 中国科学院大连化学物理研究所 | 一类640nm激发的近红外荧光染料及其制备方法 |
CN109665987A (zh) * | 2018-12-28 | 2019-04-23 | 河南大学 | 萘内酰亚胺-多胺缀合物及其制备方法和用途 |
CN111961040A (zh) * | 2020-09-03 | 2020-11-20 | 山东大学 | 一种基于咔唑基的有机双杂环近红外荧光探针及其制备方法与应用 |
CN112898282A (zh) * | 2021-01-25 | 2021-06-04 | 常州大学 | 一类D-π-A型AIE-TADF近红外发光材料及其制备方法与应用 |
CN113429421A (zh) * | 2021-07-19 | 2021-09-24 | 南京诺源医疗器械有限公司 | 一种有机小分子荧光探针的制备方法 |
CN113461707A (zh) * | 2021-08-03 | 2021-10-01 | 南京诺源医疗器械有限公司 | 一种近红外二区荧光小分子的制备方法 |
Non-Patent Citations (1)
Title |
---|
See also references of EP4183791A4 * |
Also Published As
Publication number | Publication date |
---|---|
US20240199633A1 (en) | 2024-06-20 |
EP4183791A4 (en) | 2024-03-20 |
CN113461707B (zh) | 2022-04-12 |
CN113461707A (zh) | 2021-10-01 |
EP4183791A1 (en) | 2023-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2023010925A1 (zh) | 一种近红外二区荧光小分子的制备方法 | |
CN113429421B (zh) | 一种有机小分子荧光探针的制备方法 | |
CN111303139B (zh) | 具有聚集诱导发光性能的化合物及其制备方法和应用 | |
Sheng et al. | [a]-Phenanthrene-fused BF2 azadipyrromethene (AzaBODIPY) dyes as bright near-infrared fluorophores | |
CN105669529B (zh) | 一种富勒烯吡咯烷衍生物及其制备方法 | |
CN108864733B (zh) | 一种近红外碳罗丹明荧光染料及其合成方法 | |
Liu et al. | Circularly polarized luminescence from axially chiral binaphthalene-bridged BODIPY | |
CN108503658A (zh) | 一种近红外氯化氮杂氟硼烷染料及其制备方法和应用 | |
CN109134384A (zh) | 一种聚集诱导发光氢键聚合物网络的制备方法 | |
CN106883207A (zh) | 一种三聚茚基双香豆素荧光染料的制备方法 | |
CN110041723A (zh) | 近红外第二窗口激发/发射的荧光染料及其制备方法 | |
Zhao et al. | Multicolor biomass based carbon nanodots for bacterial imaging | |
Zhu et al. | Tetraphenylethylene-and fluorene-functionalized near-infrared aza-BODIPY dyes for living cell imaging | |
CN112358493B (zh) | 一种基于氟硼配合物的小分子光热试剂及其制备方法和应用 | |
CN108558788A (zh) | 一种新型具有聚集诱导发光现象的荧光染料合成方法 | |
CN111662567A (zh) | 一种七甲川羧基吲哚花菁染料及其制备方法和应用 | |
CN109575240B (zh) | 一种高荧光量子效率的红光聚合物及量子点溶液及用途 | |
CN114230596B (zh) | 一类具有大于1200nm吸收的乙烯桥联氟硼吡咯聚集体的制备方法及其光热诊疗应用 | |
CN113603722B (zh) | 一种极性荧光探针及其制备方法和应用 | |
CN108191880A (zh) | 一种具有咔唑-罗丹明杂化结构的荧光染料制备方法和应用 | |
Aryamueang et al. | Near-infrared aza-BODIPYs bearing tetraphenylethylene: Synthesis, photophysical studies, and cell imaging application | |
WO2020181929A1 (zh) | 一种七甲川苯并吲哚花菁染料的制备方法及其应用 | |
CN113501836A (zh) | 一种星型bodipy近红外荧光染料及其制备方法 | |
CN111662565B (zh) | 一种七甲川硝基吲哚花菁染料以及该染料的制备方法和用途 | |
Nishiuchi et al. | Bent π-Conjugated System Composed of Two Dibenzocyclooctatetraene Units: Multifunctional Properties of Dynamic Molecular Tweezers in Solution and the Solid State |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 17907972 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2022754273 Country of ref document: EP Effective date: 20220824 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |